“…A significant current disadvantage in the implementation of photosensitizers based on conjugated chromophore molecules is their tendency to aggregate in aqueous media because of either general insolubility or enhancement of hydrophobic intermolecular interactions . Aggregation typically causes deactivation of photosensitizers in vivo even if excellent 1 O 2 generation properties are found in vitro . − To ameliorate for aggregation-induced effects, various nanoarchitecturing strategies, as well as numerous macroscale architectures, ,− have been proposed for the sequestration of the photosensitizer moiety to suppress deactivation. , These nanoscale architectures include the encapsulation of photosensitizers in lipid particles or colloids, , incorporation into dendrimeric , or polymeric , architectures, or inclusion of the photosensitizers in hybrid core–shell nanoparticles − or porous nanomaterials. − Multifunctional self-assembled nanostructures have also been investigated although these approaches have often involved highly technical multistep syntheses leading to complex nanosystems of limited stability or efficacy. , Conversely, compared to aggregation-induced/enhanced emission (AIEE), aggregation-induced/enhanced 1 O 2 generation by photosensitizers has hardly been demonstrated for PDT applications. − That being said, there have been several recently reported examples utilizing AIEE photosensitizers in vitro and in vivo ; , however, despite the utilization of AIEE agents, surfactants to stabilize and/or ensure biocompatibility are still required in some cases. − …”